MediciNova
MNOV
23 hedge funds and large institutions have $6.77M invested in MediciNova in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.06% less ownership
Funds ownership: 10.61% → 10.54% (-0.06%)
11% less capital invested
Capital invested by funds: $7.6M → $6.77M (-$821K)
18% less funds holding
Funds holding: 28 → 23 (-5)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$88.2K |
| 2 |
Barclays
London,
United Kingdom
|
+$47.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$328 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$319 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$49.8K |
| 2 |
Jane Street
New York
|
-$39K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$35K |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$17.6K |
| 5 |
JG
Jain Global
New York
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | -$146 | -100 | Closed |
|
|
NA
27
NewEdge Advisors
New Orleans,
Louisiana
| – | -$4 | -3 | Closed |
|
MNOV Hedge Fund Activity: Q2 2025 in Review
23 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2025, worth a combined $6.77M — down 11% from $7.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MNOV and 0 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $88.2K. The largest seller was Bank of America, cutting an estimated $49.8K.
- 23 institutional investors held MediciNova (MNOV) as of Q2 2025, down from 28 in Q1 2025.
- Funds reported $6.77M of MediciNova stock for Q2 2025, down 11% quarter-over-quarter.
- 0 funds opened new MediciNova positions in Q2 2025 and 5 closed out, a net change of -5 holders.
- The largest MediciNova buyer in Q2 2025 was Vanguard Group, an estimated $88.2K added.
- The largest MediciNova seller in Q2 2025 was Bank of America, an estimated $49.8K sold.
Based on aggregated 13F filings for Q2 2025.